Softgel Development & Pilot Capabilities
SPI Pharma's softgel development capabilities help customers move from concept to commercialization with greater confidence.
Accelerating Softgel Innovation
SPI Pharma's softgel development capabilities help customers move from concept to commercialization with greater confidence. Through our Innovation and Development Center (IDC), we support formulation development, plasticizer selection, process optimization, and pilot-scale softgel trials.
Our team combines ingredient expertise with practical softgel manufacturing knowledge to help solve formulation challenges, reduce development risk, and accelerate product launches.
Why SPI Pharma?
- Expertise in softgel shell systems
- Pilot-scale development capabilities
- Advanced plasticizer knowledge
- Data-driven process optimization
- Global technical support
- Collaborative development approach
Our Capabilities
Prototype Development
Formulation Support
Plasticizer Optimization
Process Development
Technical Troubleshooting
End‑to‑End Partnership for Successful Softgel Development
From formulation design to regulatory submission, SPI delivers the materials expertise, scientific rigor, and industry partnerships needed to turn your concept into a commercial reality.